Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of vaccination on new SARS-CoV-2 infections in the UK
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Madhumita Shrotri, Maria Krutikov, Tom Palmer, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1529-1538
Open Access | Times Cited: 186
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Nick Andrews, Elise Tessier, Julia Stowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 167
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
S Feng, Daniel J. Phillips, Thomas White, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 154
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
David W. Eyre, Sheila Lumley, Jia Wei, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 10, pp. 1516.e7-1516.e14
Open Access | Times Cited: 136
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 398-404
Open Access | Times Cited: 120
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Emil N. Iftekhar, Viola Priesemann, Rudi Balling, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100185-100185
Open Access | Times Cited: 117
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 87
Vaccines for COVID-19: Where do we stand in 2021?
Ketaki Sharma, Archana Koirala, Katrina Nicolopoulos, et al.
Paediatric Respiratory Reviews (2021) Vol. 39, pp. 22-31
Open Access | Times Cited: 87
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
Yi‐Chou Hou, Kuo‐Cheng Lu, Ko‐Lin Kuo
Vaccines (2021) Vol. 9, Iss. 8, pp. 885-885
Open Access | Times Cited: 68
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
Louise Benning, Maximilian Töllner, Åsa Hidmark, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 857-857
Open Access | Times Cited: 60
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)
Madhumita Shrotri, Ellen Fragaszy, Cyril Geismar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts
Thu Nguyen-Anh Tran, Nathan B. Wikle, Emmy Albert, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine
Piotr Rzymski, Monika Pazgan−Simon, Krzysztof Simon, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 781-781
Open Access | Times Cited: 36
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
Franziska Neumann, Ruben Rose, Janine Römpke, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 700-700
Open Access | Times Cited: 31
The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members
Jussipekka Salo, Milla Hägg, Mika Kortelainen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Wasim A. Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1409-1409
Open Access | Times Cited: 29
Kebijakan Vaksinasi COVID-19: Pendekatan Pemodelan Matematika Dinamis Pada Efektivitas Dan Dampak Vaksin Di Indonesia
Narila Mutia Nasir, Ibnu Susanto Joyosemito, Baequni Boerman, et al.
Jurnal Pengabdian kepada Masyarakat UBJ (2021) Vol. 4, Iss. 2
Open Access | Times Cited: 27
Immunogenicity of Oxford-AstraZeneca COVID-19 Vaccine in Vietnamese Health-Care Workers
Nguyen Van Vinh Chau, Lam Anh Nguyet, Nguyen Thanh Truong, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 2, pp. 556-561
Open Access | Times Cited: 20
Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review
Natsuko Imai, Alexandra B. Hogan, Lucy Williams, et al.
Wellcome Open Research (2021) Vol. 6, pp. 185-185
Open Access | Times Cited: 23
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
Mattia Trunfio, Lorenzo Richiardi, Francesca Alladio, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations: a modeling study
Billy J. Gardner, A. Marm Kilpatrick
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 17
Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show
Gareth Iacobucci
BMJ (2021), pp. n1068-n1068
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top